{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:57Z","timestamp":1792788537995,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key R&D Program of China","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Natural Science Foundation of China","award":["82300207"],"award-info":[{"award-number":["82300207"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"New Chongqing Youth Innovative Talent Project","award":["CSTB2024NSCQ-QCXMX0039"],"award-info":[{"award-number":["CSTB2024NSCQ-QCXMX0039"]}]},{"name":"the Subject Talent Construction Project of the Second Affiliated Hospital of Army Military Medical University","award":["2023XKRC015"],"award-info":[{"award-number":["2023XKRC015"]}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0654"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0654"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Central nervous system (CNS) leukemia remains a major clinical challenge in acute lymphoblastic leukemia, largely due to the restrictive nature of the blood\u2013brain barrier (BBB), which severely limits therapeutic delivery and contributes to high relapse rates and poor prognosis. Here, we report ALB-phage, a bioengineered\n                    <jats:bold>\n                      <jats:underline>a<\/jats:underline>\n                    <\/jats:bold>\n                    nti-\n                    <jats:bold>\n                      <jats:underline>l<\/jats:underline>\n                    <\/jats:bold>\n                    eukemia\n                    <jats:bold>\n                      <jats:underline>b<\/jats:underline>\n                    <\/jats:bold>\n                    ackpack\u2013phage system designed for active BBB navigation and intracranial drug delivery. M13 bacteriophages were genetically engineered to display BBB-homing ligands, forming a high-aspect-ratio biological transport platform (BTP). A leukemia-targeting therapeutic backpack (L-Pak) was constructed by encapsulating methotrexate within lipid nanoparticles fused with leukemia cell membranes, enabling homotypic targeting. The L-Pak was conjugated to the BTP via a matrix metalloproteinase-responsive PLGVR linker, allowing selective cleavage within the cerebrospinal fluid. Owing to its filamentous morphology, ALB-phage achieved efficient BBB translocation predominantly through energy-dependent macropinocytosis with an additional contribution from clathrin-mediated endocytosis. Both in vitro and in vivo studies demonstrate that ALB-phage effectively penetrates the BBB and selectively eradicates leukemia blasts, resulting in marked tumor suppression and a significant extension of median survival from 29 to 40 days in cell-line-derived xenograft models. Collectively, this M13 bacteriophage-based all-in-one platform integrates targeted BBB penetration with homology-mediated cytotoxicity, offering a promising strategy for the treatment of CNS leukemia and other central nervous system malignancies.\n                  <\/jats:p>","DOI":"10.1186\/s40364-026-01000-3","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:02:08Z","timestamp":1789527728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biohybrid M13 phage backpacks for active blood\u2013brain barrier traversal and precision central nervous system leukemia treatment"],"prefix":"10.1186","volume":"14","author":[{"given":"Wei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"5","key":"1000_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","volume":"29","author":"R Bassan","year":"2011","unstructured":"Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 2011;29(5):532\u201343.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1000_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1182\/blood.V42.3.349.349","volume":"42","author":"RJ Aur","year":"1973","unstructured":"Aur RJ, Hustu HO, Verzosa MS, Wood A, Simone JV. Comparison of two methods of preventing central nervous system leukemia. Blood. 1973;42(3):349\u201357.","journal-title":"Blood"},{"issue":"1","key":"1000_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-015-0186-5","volume":"8","author":"L Gao","year":"2015","unstructured":"Gao L, Zhang C, Gao L, Liu Y, Su Y, Wang S, Li B, Yang T, Yuan Z, Zhang X. Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China. J Hematol Oncol. 2015;8(1):90.","journal-title":"J Hematol Oncol"},{"key":"1000_CR4","doi-asserted-by":"publisher","first-page":"217264","DOI":"10.1016\/j.canlet.2024.217264","volume":"605","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chang Y-J, Chen J, Han M, Hu J, Hu J, Huang H, Lai Y, Liu D, Liu Q. Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update. Cancer Lett. 2024;605:217264.","journal-title":"Cancer Lett"},{"issue":"7716","key":"1000_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41586-018-0342-5","volume":"560","author":"H Yao","year":"2018","unstructured":"Yao H, Price TT, Cantelli G, Ngo B, Warner MJ, Olivere L, Ridge SM, Jablonski EM, Therrien J, Tannheimer S. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature. 2018;560(7716):55\u201360.","journal-title":"Nature"},{"issue":"2","key":"1000_CR6","first-page":"166","volume":"354","author":"C-H Pui","year":"2006","unstructured":"Pui C-H, Evans WE. Treatment of acute lymphoblastic leukemia, New Engl. J Med. 2006;354(2):166\u201378.","journal-title":"J Med"},{"issue":"2","key":"1000_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nrd2240","volume":"6","author":"C-H Pui","year":"2007","unstructured":"Pui C-H, Jeha S. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat Rev Drug Discov. 2007;6(2):149\u201365.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"1000_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41551-019-0434-z","volume":"3","author":"J Wen","year":"2019","unstructured":"Wen J, Wu D, Qin M, Liu C, Wang L, Xu D, Vinters HV, Liu Y, Kranz E, Guan X. Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice. Nat Biomed Eng. 2019;3(9):706\u201316.","journal-title":"Nat Biomed Eng"},{"issue":"2","key":"1000_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","volume":"101","author":"JL Rubenstein","year":"2003","unstructured":"Rubenstein JL, Combs D, Rosenberg J, Levy A, McDermott M, Damon L, Ignoffo R, Aldape K, Shen A, Lee D. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 2003;101(2):466\u20138.","journal-title":"Blood"},{"issue":"6","key":"1000_CR10","doi-asserted-by":"publisher","first-page":"2209219","DOI":"10.1002\/adfm.202209219","volume":"33","author":"D Lin","year":"2023","unstructured":"Lin D, Wang Z, Long W, Xu M, Liu A, Gao Y, Wen Z, Liu C, He J, Cheng Y. Nanosonosensitizer-Augmented Sono\u2010Immunotherapy for Glioblastoma by Non\u2010Invasive Opening of the Blood\u2013Brain Barrier. Adv Funct Mater. 2023;33(6):2209219.","journal-title":"Adv Funct Mater"},{"issue":"3","key":"1000_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41563-023-01481-9","volume":"22","author":"DE Tylawsky","year":"2023","unstructured":"Tylawsky DE, Kiguchi H, Vaynshteyn J, Gerwin J, Shah J, Islam T, Boyer JA, Bou\u00e9 DR, Snuderl M, Greenblatt MB. P-selectin-targeted nanocarriers induce active crossing of the blood\u2013brain barrier via caveolin-1-dependent transcytosis. Nat Mater. 2023;22(3):391\u20139.","journal-title":"Nat Mater"},{"key":"1000_CR12","doi-asserted-by":"publisher","first-page":"eabj4011","DOI":"10.1126\/scitranslmed.abj4011","volume":"13","author":"Y Meng","year":"2021","unstructured":"Meng Y, Reilly R, Pezo R, Trudeau M, Sahgal A, Singnurkar A, Perry J, Myrehaug S, Pople C, Davidson B. MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases. Sci Transl Med. 2021;13:eabj4011.","journal-title":"Sci Transl Med"},{"key":"1000_CR13","doi-asserted-by":"publisher","first-page":"114539","DOI":"10.1016\/j.addr.2022.114539","volume":"190","author":"J Wang","year":"2022","unstructured":"Wang J, Li Z, Pan M, Fiaz M, Hao Y, Yan Y, Sun L, Yan F. Ultrasound-mediated blood\u2013brain barrier opening: An effective drug delivery system for theranostics of brain diseases. Adv Drug Delive Rev. 2022;190:114539.","journal-title":"Adv Drug Delive Rev"},{"issue":"21","key":"1000_CR14","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1016\/j.biomaterials.2011.03.031","volume":"32","author":"J Li","year":"2011","unstructured":"Li J, Feng L, Fan L, Zha Y, Guo L, Zhang Q, Chen J, Pang Z, Wang Y, Jiang X. Targeting the brain with PEG\u2013PLGA nanoparticles modified with phage-displayed peptides. Biomaterials. 2011;32(21):4943\u201350.","journal-title":"Biomaterials"},{"issue":"5","key":"1000_CR15","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1021\/acsnano.2c09752","volume":"17","author":"Y Sun","year":"2023","unstructured":"Sun Y, Kong J, Ge X, Mao M, Yu H, Wang Y. An antisense oligonucleotide-loaded blood\u2013brain barrier penetrable nanoparticle mediating recruitment of endogenous neural stem cells for the treatment of Parkinson\u2019s disease. ACS Nano. 2023;17(5):4414\u201332.","journal-title":"ACS Nano"},{"issue":"10","key":"1000_CR16","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1021\/acs.nanolett.3c00563","volume":"23","author":"J Lu","year":"2023","unstructured":"Lu J, Ding J, Chu B, Ji C, Zhang Q, Xu Y, Song B, Wang H, He Y. Inactive trojan bacteria as safe drug delivery vehicles crossing the blood\u2013brain barrier. Nano Lett. 2023;23(10):4326\u201333.","journal-title":"Nano Lett"},{"issue":"2","key":"1000_CR17","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1021\/acsnano.2c10219","volume":"17","author":"J Cui","year":"2023","unstructured":"Cui J, Wang X, Li J, Zhu A, Du Y, Zeng W, Guo Y, Di L, Wang R. Immune exosomes loading self-assembled nanomicelles traverse the blood\u2013brain barrier for chemo-immunotherapy against glioblastoma. ACS Nano. 2023;17(2):1464\u201384.","journal-title":"ACS Nano"},{"issue":"11","key":"1000_CR18","doi-asserted-by":"publisher","first-page":"2210262","DOI":"10.1002\/adma.202210262","volume":"35","author":"C Shi","year":"2023","unstructured":"Shi C, Zhang J, Wang H, Chen C, Han M, Gao L, Tang C, Sun P, Zhao X, Guo F. Trojan horse nanocapsule enabled in situ modulation of the phenotypic conversion of Th17 cells to treg cells for the treatment of multiple sclerosis in mice. Adv Mater. 2023;35(11):2210262.","journal-title":"Adv Mater"},{"issue":"6","key":"1000_CR19","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.cell.2025.01.017","volume":"188","author":"H Shen","year":"2025","unstructured":"Shen H, Aggarwal N, Cui B, Foo GW, He Y, Srivastava SK, Li S, Seah MZX, Wun KS, Ling H. Engineered commensals for targeted nose-to-brain drug delivery. Cell. 2025;188(6):1545\u201362. e16.","journal-title":"Cell"},{"key":"1000_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","volume":"281","author":"M Agrawal","year":"2018","unstructured":"Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Controlled Release. 2018;281:139\u201377.","journal-title":"J Controlled Release"},{"key":"1000_CR21","doi-asserted-by":"publisher","first-page":"102536","DOI":"10.1016\/j.nantod.2024.102536","volume":"59","author":"X Dong","year":"2024","unstructured":"Dong X, Wu W, Zhang C-L, Huang R-H, Wen Q, Zhang X. Virus-mimicking nanodrug active crossing of the blood-brain barrier via transcytosis against central nervous system leukemia. Nano Today. 2024;59:102536.","journal-title":"Nano Today"},{"issue":"1","key":"1000_CR22","doi-asserted-by":"publisher","first-page":"eadz9069","DOI":"10.1126\/sciadv.adz9069","volume":"12","author":"Y Yu","year":"2026","unstructured":"Yu Y, Bu Y, Shen C, Lin B, Lu C, Zhu L, Shen Z, Li C, Li X. Bacteriocin-transport\u2013inspired oral peptide-probiotic delivery ameliorates IBD complications via autophagy and gut homeostasis. Sci Adv. 2026;12(1):eadz9069.","journal-title":"Sci Adv"},{"issue":"33","key":"1000_CR23","doi-asserted-by":"publisher","first-page":"e70227","DOI":"10.1002\/adma.70227","volume":"37","author":"D Zhang","year":"2025","unstructured":"Zhang D, Wang X, Li W, Wan D, Zhou Y, Ma C, Yang Z, Zhang Y, Li W, Li Z. A Single-Cell atlas\u2010inspired hitchhiking therapeutic strategy for acute pancreatitis by restricting ros in neutrophils. Adv Mater. 2025;37(33):e70227.","journal-title":"Adv Mater"},{"issue":"26","key":"1000_CR24","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.1073\/pnas.1308345110","volume":"110","author":"P Kolhar","year":"2013","unstructured":"Kolhar P, Anselmo AC, Gupta V, Pant K, Prabhakarpandian B, Ruoslahti E, Mitragotri S. Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci USA. 2013;110(26):10753\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1000_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1084\/jem.78.3.161","volume":"78","author":"RJ Dubos","year":"1943","unstructured":"Dubos RJ, Straus JH, Pierce C. The multiplication of bacteriophage in vivo and its protective effect against an experimental infection with Shigella dysenteriae. J Exp Med. 1943;78(3):161.","journal-title":"J Exp Med"},{"issue":"20","key":"1000_CR26","doi-asserted-by":"publisher","first-page":"eaba1590","DOI":"10.1126\/sciadv.aba1590","volume":"6","author":"X Dong","year":"2020","unstructured":"Dong X, Pan P, Zheng D-W, Bao P, Zeng X, Zhang X-Z. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer. Sci Adv. 2020;6(20):eaba1590.","journal-title":"Sci Adv"},{"key":"1000_CR27","doi-asserted-by":"publisher","first-page":"121763","DOI":"10.1016\/j.biomaterials.2022.121763","volume":"289","author":"X Dong","year":"2022","unstructured":"Dong X, Pan P, Ye J-J, Zhang Q-L, Zhang X-Z. Hybrid M13 bacteriophage-based vaccine platform for personalized cancer immunotherapy. Biomaterials. 2022;289:121763.","journal-title":"Biomaterials"},{"issue":"6","key":"1000_CR28","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1073\/pnas.1809483116","volume":"116","author":"FH Tang","year":"2019","unstructured":"Tang FH, Staquicini FI, Teixeira AA, Michaloski JS, Namiyama GM, Taniwaki NN, Setubal JC, Da Silva AM, Sidman RL, Pasqualini R. A ligand motif enables differential vascular targeting of endothelial junctions between brain and retina. Proc Natl Acad Sci USA. 2019;116(6):2300\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1000_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/ijnp\/pyaa049","volume":"23","author":"W Omori","year":"2020","unstructured":"Omori W, Hattori K, Kajitani N, Okada-Tsuchioka M, Boku S, Kunugi H, Okamoto Y, Takebayashi M. Increased matrix metalloproteinases in cerebrospinal fluids of patients with major depressive disorder and schizophrenia. Int J Neuropsychoph. 2020;23(11):713\u201320.","journal-title":"Int J Neuropsychoph"},{"issue":"1","key":"1000_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.leukres.2009.10.007","volume":"34","author":"CA Scrideli","year":"2010","unstructured":"Scrideli CA, Cortez MAA, Yunes JA, de Paula RG, Queir\u00f3z ET, Valera JF, da Mata SRC, Toledo P, Pavoni-Ferreira ML, de Martino Lee AS, Petrilli. mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: potential role of TIMP1 as an adverse prognostic factor. Leuk Res. 2010;34(1):32\u20137.","journal-title":"Leuk Res"},{"issue":"11","key":"1000_CR31","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1002\/eji.1830241106","volume":"24","author":"AS Chan","year":"1994","unstructured":"Chan AS, Reynolds PJ, Shimizu Y. Tyrosine kinase activity associated with the CD7 antigen: correlation with regulation of T cell integrin function. Eur J Immunol. 1994;24(11):2602\u20138.","journal-title":"Eur J Immunol"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-01000-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-01000-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-01000-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:02:14Z","timestamp":1789527734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-01000-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1000"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-01000-3","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were reviewed and approved by the Laboratory Animal Welfare and Ethics Committee of the Army Medical University (AMUWEC20234688). The experimental design, procedures, and methods of animal euthanasia complied with the committee\u2019s animal ethics and animal welfare requirements. All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals and the relevant national regulations on the administration of laboratory animals in China. Reporting of animal experiments followed the ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"123"}}